[ad_1]
Check-in 2020.09.18 06:00
National production during the year is unclear due to disputes over technology ownership
An optical company that produces light-emitting diode (LED) lighting on the 18th GV (045890)(Golden) According to an official, legal disputes occurred in Israel until recently, and the domestic and Asian supply projects that GV decided to continue with are currently on hold. The official said: “The two parties were progressing steadily (the supply business), but the railway suddenly blew up and is pending progress,” he said. “The timeline for change in the future has not been specifically set.”
On July 7, GV signed a business agreement (MOU) with a research team from Ben Gurion University (BGU) in Israel, Gaby Sarusi, for a rapid diagnostic kit project that allows it to verify results in one minute. It has announced plans to start mass production at a national plant for supply.
However, some two weeks later, on July 20, Professor Sarushi was involved in a court battle for two months to this month over ownership of the technology, and some research activities and domestic and Asian supply projects were suspended. The supply business, which had been up for half a year since early July, has not started properly for the second month to this day.
According to local Israeli media ‘CTech’ at the time, a foreign company called ‘Ram Group’ claimed ownership of the diagnostic kit technology and petitioned the Tel Aviv District Court to halt development of the kit by the team of the Professor Sarusi. I requested it. It is argued that the idea of developing the technology is theirs, and Professor Sarushi’s team just took the drawings and made the kit. Because of this, investors on Professor Sarusi’s side withdrew a total investment promise of $ 8 million (about 9.4 billion won).
At the time of signing the MOU with GV, it is reported that Professor Sarushi’s team was seeking approval for emergency use from the United States Food and Drug Administration (FDA) and a follow-up study to track the date when infection was confirmed with this kit.
The Israeli court rejected the request for an interim injunction on the 9th (local time) saying that there was insufficient evidence, and the news that Professor Sarushi’s team could resume research and development was recently reported by local media, ` Jewish business news. Transmitted through ‘. However, until this day after a week, GV did not officially identify this, and it was confirmed that there was no discussion about the resumption of cooperation with Professor Sarushi’s team. A GV official said the day that “we are awaiting the results” and “we have not been able to understand in detail” the local situation.
GV entered the Corona 19 diagnostic kit business because this kit was manufactured using an optical principle called “ terahertz (THz, 1 trillion Hz) spectroscopy. ” According to foreign media such as Eurekalert, a scientific outlet, the electronic chip sensor integrated in the end of the kit detects the characteristics of light that has a frequency of terahertz. When this light passes through particles with a size of 100 nanometers (nm · billionth of a meter), including viruses, their properties change. By detecting this change, the Corona 19 virus can be detected.
The diagnostic kit looks like a whistle. When a user exhales as if doing a breath test, they check for Corona 19 infection in one minute. According to foreign media, Professor Sarushi’s team showed more than 90% diagnostic accuracy in the early stages of a clinical trial conducted with the Israeli Defense Ministry on 150 subjects. “The price per kit is $ 50 (about 59,000 won), which is cheaper than the ‘reverse transcription polymerase chain reaction (RT-PCR · molecular diagnostics)’ test,” the research team explained. The achievements of Professor Sarushi’s team were presented through the national and international media in May.
Jung Eun-kyung, head of the quarantine countermeasures headquarters, said in a regular briefing on the 17th: “The PCR test used by quarantine authorities can diagnose early and accurately diagnose even if there is only a small amount of viruses, but the rapid diagnostic kit will only test positive if there is a large amount of virus in the body. The sensitivity is considerably lower than that of the PCR test, “he said. Quick “. If people infected with a small amount of virus are not filtered, gaps will be created in the quarantine.
Jung explained that the World Health Organization (WHO) and the United States’ Centers for Disease Control and Prevention (CDC) also recommend that the rapid diagnostic kit not be used as a test method for Corona 19.
